Blood Cancers | Tumor

The FDA Grants ODD to OPN-6602 For Relapsed/Refractory Myeloma

February 18th 2025, 4:00pm

Article

The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or refractory multiple myeloma.

Breaking Down the Implications of Calquence Combination Therapy in MCL

February 13th 2025, 2:00pm

Video

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma.

Bold Goal, Bold Action

February 4th 2025, 9:27pm

Article

As we observe World Cancer Day, I’m reflecting on my own family’s experience with blood cancer.

Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia

January 30th 2025, 10:00pm

Article

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission following second-line salvage therapy.

Life After MDS and Accomplishing Your Goals

January 28th 2025, 6:00pm

Article

After a long and difficult journey, I finally published the book I set out to write as my legacy, overcoming cancer and the challenges of deafness.

Whitesnake Guitarist John Sykes Died of Cancer, Mike Peters Starting CAR-T

January 24th 2025, 4:00pm

Article

From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s this week’s cancer news.

Putting an Emphasis on Patient Collaboration in MPN Treatment

January 6th 2025, 2:00pm

Video

Dr. Richard “Rick" Winneker discussed advice that he would provide to patients faced with a myeloproliferative neoplasm diagnosis.

Top 4 Stories From the 2024 ASH Annual Meeting

December 24th 2024, 4:00pm

Article

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple myeloma and other blood cancers.

Ryoncil Receives FDA Approval for Children With GVHD

December 18th 2024, 10:45pm

Article

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.

Pregnancy-Associated Hematological Malignancies Linked With Complications

November 29th 2024, 4:00pm

Article

Researchers have found an increased frequency of severe maternal morbidity and obstetric complications among women who received a diagnosis of a hematological malignancy during pregnancy.